keyword
https://read.qxmd.com/read/38626556/the-orientation-of-cpg-conjugation-on-aluminum-oxyhydroxide-nanoparticles-determines-the-immunostimulatory-effects-of-combination-adjuvants
#1
JOURNAL ARTICLE
Zhihui Liang, Hang Bao, Zhiying Yao, Min Li, Chen Chen, Lei Zhang, Huiyang Wang, Yiyang Guo, Yubin Ma, Xuecheng Yang, Ge Yu, Jiancheng Zhang, Changying Xue, Bingbing Sun, Chuanbin Mao
In subunit vaccines, aluminum salts (Alum) are commonly used as adjuvants, but with limited cellular immune responses. To overcome this limitation, CpG oligodeoxynucleotides (ODNs) have been used in combination with Alum. However, current combined usage of Alum and CpG is limited to linear mixtures, and the underlying interaction mechanism between CpG and Alum is not well understood. Thus, we propose to chemically conjugate Alum nanoparticles and CpG (with 5' or 3' end exposed) to design combination adjuvants...
April 11, 2024: Biomaterials
https://read.qxmd.com/read/38598749/autoantigenic-peptide-and-immunomodulator-codelivery-system-for-rheumatoid-arthritis-treatment-by-reestablishing-immune-tolerance
#2
JOURNAL ARTICLE
Yaping Mai, Xueting Yu, Ting Gao, Yaya Wei, Tingting Meng, Wenbao Zuo, Jianhong Yang
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by abnormal activation of CD4+ T cells and an imbalance of T helper 17 (Th17) and regulatory T (Treg) cells. Tolerogenic therapy via administration of self-antigens is a promising strategy for RA treatment, but delivery of autoantigens alone may exacerbate disease conditions. Current studies indicated that codelivery of autoantigens with immunomodulators can lead to a more tolerogenic immune response. Here, we constructed an autoantigen type II collagen peptide (CII250-270 )- and immunomodulator leflunomide (LEF)-coloaded phosphatidylserine liposome vaccine (CII250-270 -LEF-PSL) for RA treatment via induction of tolerant dendritic cells (tolDC) for further activation of Treg cells...
April 10, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38576607/-mycobacterium-bovis-bcg-as-immunostimulating-agent-prevents-the-severe-form-of-chronic-experimental-chagas-disease
#3
JOURNAL ARTICLE
Minerva Arce-Fonseca, Dulce Mata-Espinosa, Alberto Aranda-Fraustro, José Luis Rosales-Encina, Mario Alberto Flores-Valdez, Olivia Rodríguez-Morales
INTRODUCTION: There is currently no vaccine against Chagas disease (ChD), and the medications available confer multiple side effects. Mycobacterium bovis Bacillus Calmette-Guérin (BCG) produces balanced Th1, Th2, and Th17 modulatory immune responses and has improved efficacy in controlling chronic infections through nonspecific immunity. We aimed to improve the response to infection by inducing a stronger immune response and greater protection against the parasite by trained immunity...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38558085/chitosan-leoa-dna-nanoparticles-promoted-the-efficacy-of-novel-leoa-dna-vaccination-on-mice-against-helicobacter-pylori
#4
JOURNAL ARTICLE
Zahra Ahmadzadeh Chaleshtori, Ali Asghar Rastegari, Hashem Nayeri, Abbas Doosti
More than half of the world's population is infected with Helicobacter pylori (H. pylori), which may lead to chronic gastritis, peptic ulcers, and stomach cancer. LeoA, a conserved antigen of H. pylori, aids in preventing this infection by triggering specific CD3+ T-cell responses. In this study, recombinant plasmids containing the LeoA gene of H. pylori are created and conjugated with chitosan nanoparticle (CSNP) to immunize BALB/c mice against the H. pylori infection. We used the online Vaxign tool to analyze the genomes of five distinct strains of H...
April 1, 2024: Current Microbiology
https://read.qxmd.com/read/38543967/baculovirus-vector-based-varicella-zoster-virus-vaccine-as-a-promising-alternative-with-enhanced-safety-and-therapeutic-functions
#5
JOURNAL ARTICLE
Chanyeong Lee, Minjee Kim, Jungmin Chun, Sehyun Kim, Doyoung Yoon, Hyeondong Lee, Heewon Bang, Hee-Jung Lee, Hosun Park, Young Bong Kim
Varicella-zoster virus (VZV) poses lifelong risks, causing varicella and herpes zoster (HZ, shingles). Currently, varicella and HZ vaccines are predominantly live attenuated vaccines or adjuvanted subunit vaccines utilizing VZV glycoprotein E (gE). Here, we propose our vaccine candidates involving a comparative analysis between recombinant baculoviral vector vaccines (AcHERV) and a live attenuated vaccine strain, vOka. AcHERV vaccine candidates were categorized into groups encoding gE only, VZV glycoprotein B (gB) only, or both gE and gB (gE-gB) as AcHERV-gE, AcHERV-gB, and AcHERV-gE-gB, respectively...
March 20, 2024: Vaccines
https://read.qxmd.com/read/38503757/design-of-hepadnavirus-core-protein-based-chimeric-virus-like-particles-carrying-epitopes-from-respiratory-syncytial-virus
#6
JOURNAL ARTICLE
Shuai Shao, Xue Feng Zhang, Jun Wei Hou, Sen Sen Yang, Zi Bo Han, Hai Lan Wu, Fang Tang, Xin Yu Li, Ze Hua Lei, Zi Xin Zhao, Shu Xiang Li, Zhao Ming Liu, Pu Shan, Yu Qin Jin, Ji Guo Su, Yu Liang, Jing Zhang, Qi Ming Li
Respiratory syncytial virus (RSV) is one of the most important pathogens causing respiratory tract infection in humans, especially in infants and the elderly. The identification and structural resolution of the potent neutralizing epitopes on RSV fusion (F) protein enable an "epitope-focused" vaccine design. However, the display of RSV F epitope II on the surface of the widely-used human hepatitis B virus core antigen (HBcAg) has failed to induce neutralizing antibody response in mice. Here, we used the hepadnavirus core protein (HcAg) from different mammalian hosts as scaffolds to construct chimeric virus-like particles (VLPs) presenting the RSV F epitope II...
March 19, 2024: NPJ Vaccines
https://read.qxmd.com/read/38496534/a-tlr7-agonist-conjugated-to-a-nanofibrous-peptide-hydrogel-as-a-potent-vaccine-adjuvant
#7
Erin M Euliano, Brett H Pogostin, Anushka Agrawal, Marina H Yu, Tsvetelina H Baryakova, Tyler P Graf, Jeffrey D Hartgerink, Kevin J McHugh
UNLABELLED: Toll-like receptors (TLRs) recognize pathogen- and damage-associated molecular patterns and, in turn, trigger the release of cytokines and other immunostimulatory molecules. As a result, TLR agonists are increasingly being investigated as vaccine adjuvants, though many of these agonists are small molecules that quickly diffuse away from the vaccination site, limiting their co-localization with antigens and, thus, their effect. Here, the small-molecule TLR7 agonist 1V209 is conjugated to a positively-charged multidomain peptide (MDP) hydrogel, K 2 , which was previously shown to act as an adjuvant promoting humoral immunity...
March 9, 2024: bioRxiv
https://read.qxmd.com/read/38463854/immunogenicity-and-protective-efficacy-of-ag85a-and-truncation-of-psts1-fusion-protein-vaccines-against-tuberculosis
#8
JOURNAL ARTICLE
Lingyuan Zeng, Xiuling Ma, Mengjin Qu, Minghui Tang, Huoming Li, Chengrui Lei, Jiahong Ji, Hao Li
Tuberculosis (TB) is an important public health problem, and the One Health approach is essential for controlling zoonotic tuberculosis. Therefore, a rationally designed and more effective TB vaccine is urgently needed. To enhance vaccine efficacy, it is important to design vaccine candidates that stimulate both cellular and humoral immunity against TB. In this study, we fused the secreted protein Ag85A as the T cell antigen with truncated forms of the mycobacterial cell wall protein PstS1 with B cell epitopes to generate vaccine candidates, Ag85A-tnPstS1 (AP1, AP2, and AP3), and tested their immunogenicity and protective efficacy in mice...
March 15, 2024: Heliyon
https://read.qxmd.com/read/38453620/pires2-egfp-ctb-urei-vaccination-activated-a-mixed-th1-th2-th17-immune-system-defense-towards-helicobacter-pylori-infection-in-the-balb-c-mice-model
#9
JOURNAL ARTICLE
Sana Ghasemifar, Omid Chabak, Tohid Piri-Gharaghie, Abbas Doosti
The occurrence of gastritis, gastric ulcers, distal gastric cancer, and gastric mucosal lymphoma in humans is strongly associated with Helicobacter pylori (H. pylori). Vaccination is an effective preventive measure due to the increasing prevalence of antibiotic resistance. Fusion vaccination is a potentially practical approach. A fusion vaccine was created in this study by combining the cholera toxin B subunit (CTB) with the antigenic H. pylori urease I subunit (CTB-UreI). The CTB-UreI DNA vaccine was chemically cloned into pIRES2-EGFP, and the success of the cloning was validated using PCR and restriction enzyme digestion...
March 7, 2024: Vaccine
https://read.qxmd.com/read/38428517/a-comprehensive-method-for-the-phenotypical-and-functional-characterization-of-recalled-human-memory-b-and-t-cells-specific-to-vaccine-antigens
#10
JOURNAL ARTICLE
Czdari Lee, Imtisal Imran, Sara Thomas, Mahyar Nouri-Shirazi
Current methodologies for assessing vaccine effectiveness and longevity primarily center on measuring vaccine-induced neutralizing antibodies in serum or plasma. However, these methods overlook additional parameters such as the presence of memory B cells, even as antibody levels wane, and the pivotal role played by memory T cells in shaping antigen-specific memory B cell responses. Several studies have employed a combination of polyclonal activators, such as CpG and R848, along with various cytokines to provoke the recall of memory B cells from peripheral blood mononuclear cells (PBMCs) into antibody-secreting cells (ASCs)...
February 28, 2024: Journal of Immunological Methods
https://read.qxmd.com/read/38400157/immunogenicity-and-tolerance-of-bnt162b2-mrna-vaccine-in-allogeneic-hematopoietic-stem-cell-transplant-patients
#11
JOURNAL ARTICLE
Ahmed Amine Ben Khlil, Imen Zamali, Dorra Belloumi, Mariem Gdoura, Ghassen Kharroubi, Soumaya Marzouki, Rym Dachraoui, Insaf Ben Yaiche, Soumaya Bchiri, Walid Hamdi, Manel Gharbi, Ahlem Ben Hmid, Samar Samoud, Yousr Galai, Lamia Torjmane, Saloua Ladeb, Jihene Bettaieb, Henda Triki, Nour Ben Abdeljelil, Tarek Ben Othman, Melika Ben Ahmed
BACKGROUND: Allogeneic hematopoietic stem cell transplantation (ASCT) induces acquired immunodeficiency, potentially altering vaccine response. Herein, we aimed to explore the clinical tolerance and the humoral and cellular immune responses following anti-SARS-CoV-2 vaccination in ASCT recipients. METHODS: A prospective, non-randomized, controlled study that involved 43 ASCT subjects and 31 healthy controls. Humoral response was investigated using the Elecsys® test anti-SARS-CoV-2...
February 8, 2024: Vaccines
https://read.qxmd.com/read/38385416/transforming-growth-factor-%C3%AE-1-c-869-t-codon-10-gene-polymorphism-significantly-associated-with-rates-of-sars-cov-2-in-kidney-transplant-recipients-in-kuwait
#12
JOURNAL ARTICLE
Mohamed Jahromi, Torki Al Otaibi, Nashwa Othman, Tarek Mahmoud, Prasad Nair, Medhat A Halim, Osama Gheith
OBJECTIVES: COVID-19, which began in Wuhan, China, in December 2019, has caused a large global pandemic and poses a serious threat to public health. As of March 20, 2023, over 13 billion COVID-19 vaccine doses had been administered worldwide, with the United States accounting for almost 672 million of total administered vaccine doses. Some COVID-19 patients experience sudden and rapid deterioration with onset of fatal cytokine storm syndrome, which increased interest in the mechanisms, diagnosis, and therapy of cytokine storm syndrome...
January 2024: Experimental and Clinical Transplantation
https://read.qxmd.com/read/38376908/alginate-di-aldehyde-modified-metal-organic-framework-nanocarriers-as-delivery-platform-and-adjuvant-in-inactivated-pseudorabies-vaccination
#13
JOURNAL ARTICLE
Wenzhu Yin, Zeyu Xu, Chen Chang, Yanhong Zhao, Haiyan Wang, Jinqiu Zhang, Fang Ma, Xiaoxin Zuo, Bo Tang, Yu Lu
Pseudorabies virus (PRV) is a highly contagious viral disease, which leads to severe financial losses in the breeding industry worldwide. Presently, PRV is mainly controlled using live attenuated and inactivated vaccines. However, these vaccines have an innate tendency to lose their structural conformation upon exposure to environmental and chemical stressors and cannot provide full protection against the emerging prevalent PRV variants. In this work, first, we synthesized aminated ZIF-7/8 nanoparticles (NPs), and then chemical bond-coated alginate dialdehyde (ADA, a type of dioxide alginate saccharide) on their surface via Schiff base reaction to obtain ZIF-7/8-ADA NPs...
February 20, 2024: Materials Horizons
https://read.qxmd.com/read/38374807/pregnant-individuals-with-uncomplicated-pregnancies-display-pro-inflammatory-immune-changes-when-exposed-to-the-covid-19-pandemic
#14
JOURNAL ARTICLE
Elsa Bernier, Marie-Eve Brien, Sylvie Girard
PROBLEM: The COVID-19 pandemic has been shown to have a detrimental impact on the mental health of pregnant individuals, and chronic stress can alter the immune profile. However, the effects of the COVID-19 pandemic on the immune system in pregnancy are still poorly understood. We aimed to evaluate the impact of pandemic exposure on the maternal immune profile in uncomplicated pregnancies. METHOD OF STUDY: We collected blood and placenta samples from pregnant individuals exposed and unexposed to the pandemic to compare their immune and inflammatory profiles...
February 2024: American Journal of Reproductive Immunology: AJRI
https://read.qxmd.com/read/38364954/evaluation-of-the-immunoprotective-effect-of-the-recombinant-eimeria-intestinalis-rhoptry-protein-25-and-rhoptry-protein-30-on-new-zealand-rabbits
#15
JOURNAL ARTICLE
Ge Hao, Changming Xiong, Jie Xiao, Wei He, Yuhua Zhu, Liwen Xu, Qing Jiang, Guangyou Yang
BACKGROUND: Rabbit coccidiosis is a parasitism caused by either one or multiple co-infections of Eimeria species. Among them, Eimeria intestinalis is the primary pathogen responsible for diarrhea, growth retardation, and potential mortality in rabbits. Concerns regarding drug resistance and drug residues have led to the development of recombinant subunit vaccines targeting Eimeria species as a promising preventive measure. The aim of this study was to assess the immunoprotective efficacy of recombinant subunit vaccines comprising EiROP25 and EiROP30 (rhoptry proteins (ROPs)) against E...
February 14, 2024: Experimental Parasitology
https://read.qxmd.com/read/38359558/cytokine-responses-to-major-human-cytomegalovirus-antigens-in-mouse-model
#16
JOURNAL ARTICLE
Sahar Essa, Hussain A Safar, Raj Raghupathy
Human cytomegalovirus (CMV) continues to be a source of severe complications in immunologically immature and immunocompromised hosts. Effective CMV vaccines that help diminish CMV disease in transplant patients and avoid congenital infection are essential. Though the exact roles of defense mechanisms are unidentified, virus-specific antibodies and cytokine responses are known to be involved in controlling CMV infections. Identifying the CMV antigens that trigger these protective immune responses will help us choose the most suitable CMV-related proteins for future vaccines...
February 14, 2024: Cytokine
https://read.qxmd.com/read/38354941/cistanche-deserticola-polysaccharide-functionalized-dendritic-fibrous-nano-silica-as-oral-vaccine-adjuvant-delivery-enhancing-both-the-mucosal-and-systemic-immunity
#17
JOURNAL ARTICLE
Jin He, Tianyu Zhu, Ningning Mao, Gaofeng Cai, Pengfei Gu, Zuchen Song, Xuanqi Lu, Yang Yang, Deyun Wang
Oral vaccines are a safe and convenient alternative to injected vaccines and have great potential to prevent major infectious diseases. However, the harsh gastrointestinal (GI) environment, mucus barriers, low immunogenicity, and lack of effective and safe mucosal adjuvants are the major challenges for oral vaccine delivery. In recent years, nanoparticle-based strategies have become attractive for improving oral vaccine delivery. Here, the dendritic fibrous nano-silica (DFNS) grafted with Cistanche deserticola polysaccharide (CDP) nanoparticles (CDP-DFNS) were prepared and investigated how to impact the immune responses...
February 12, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38346161/potential-gastric-cancer-immunotherapy-stimulating-the-immune-system-with-helicobacter-pylori-pires2-dsred-express-uref-dna-vaccines
#18
JOURNAL ARTICLE
Mahsa Afkhamipour, Fatemeh Kaviani, Samaneh Dalali, Tohid Piri-Gharaghie, Abbas Doosti
Most gastric cancers (GC) are thought to be caused by Helicobacter pylori ( H. pylori ) infections. However, there is mounting evidence that GC patients with positive H. pylori status have improved prognoses. The H. pylori -induced cellular immune reaction may inhibit cancer. In this study, BALB/c mice were immunized using recombinant plasmids that encode the ureF gene of H. pylori . Purified functional splenic CD3+ T lymphocytes are used to study the anticancer effects in vitro and in vivo . The immunological state of GC patients with ongoing H...
January 1, 2024: Archivum Immunologiae et Therapiae Experimentalis
https://read.qxmd.com/read/38303776/bpompw-antigen-administered-with-caf01-adjuvant-stimulates-comparable-t-cell-responses-to-sigma-adjuvant-system
#19
JOURNAL ARTICLE
Julen Tomás-Cortázar, Conor Quinn, Niamh Corcoran, Alfonso Blanco, Dennis Christensen, Siobhán McClean
There are no licensed vaccines to protect vulnerable populations from the potentially fatal tropical infection, melioidosis, despite its causative agent, Burkholderia pseudomallei, being endemic in tropical and subtropical regions. A promising vaccine candidate, BpOmpW protected mice from melioidosis infection for up to 81 days and stimulated robust interferon gamma responses in CD4+ , CD8+ , NK and NKT cells. In order to progress to human studies, selection of an adjuvant with an acceptable human safety profile that stimulates appropriate correlates of protection is essential...
March 2024: Vaccine: X
https://read.qxmd.com/read/38278364/plant-stanol-consumption-increases-anti-covid-19-antibody-responses-independent-of-changes-in-serum-cholesterol-concentrations-a-randomized-controlled-trial
#20
JOURNAL ARTICLE
Lieve van Brakel, Ronald P Mensink, Dieter Lütjohann, Jogchum Plat
BACKGROUND: People with overweight/obesity generally have impaired immune responses, resulting among others in increased risk of severe complaints and hospitalization after infections with severe acute respiratory syndrome coronavirus 2 (COVID-19), as well as decreased antibody production after vaccinations. Plant stanol ester previously increased the combined IgM/IgG antibody titers toward a hepatitis A vaccination in patients with allergic asthma, but the underlying mechanism is unknown...
January 24, 2024: American Journal of Clinical Nutrition
keyword
keyword
166638
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.